Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
-
UPDATE: Argus Downgrades Eli Lilly (LLY) to Hold Citing Regulatory Setbacks
-
Notable Analyst Rating Changes 11/11: (BBY) (AMT) (GPOR) Upgraded; (LLY) (PENN) (KLAC) Downgraded
-
Notable Analyst Rating Changes 02/14: (CVE) (WSM) (MYL) Upgraded; (BAC) (YGE) (STI) Downgraded
-
Argus Upgrades Eli Lilly (LLY) to Buy
-
Notable Analyst Rating Changes 04/20: POT, MWW, IPG, PNK, IEX Upgraded; LLY, GCA, WDR Downgraded
-
David Moenning's Daily State of the Markets: 4/20
-
ARGUS Downgrades Eli Lilly (LLY) to Hold